Standard triple versus levofloxacin based regimen for eradication of Helicobacter pylori

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 4, Issue 2

This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

256

HTML

2297

Figures (1-1)

138

Tables (1-1)

151

Sum=2842

Publishing Process of This Article

Item

Count

Browse

894

Download

869

Sum=1763

May 6, 2013 (publication date) through May 20, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastrointestinal Pharmacology and Therapeutics

ISSN

2150-5349

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Brief Article

World J Gastrointest Pharmacol Ther. May 6, 2013; 4(2): 23-27
Published online May 6, 2013. doi: 10.4292/wjgpt.v4.i2.23

Figure 1 Schematic representation of the design of the study. DU: Duodenal ulcer; H. pylori: Helicobacter pylori.

Citation: Gopal R, Elamurugan TP, Kate V, Jagdish S, Basu D. Standard triple versus levofloxacin based regimen for eradication of Helicobacter pylori. World J Gastrointest Pharmacol Ther 2013; 4(2): 23-27
URL: https://www.wjgnet.com/2150-5349/full/v4/i2/23.htm
DOI: https://dx.doi.org/10.4292/wjgpt.v4.i2.23